Medexus Pharmaceuticals Valuation
| MDP Stock | 2.86 0.12 4.38% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. Medexus Pharmaceuticals secures a last-minute Real Value of USD2.79 per share. The latest price of the firm is USD2.86. Our model forecasts the value of Medexus Pharmaceuticals from analyzing the firm fundamentals such as insignificant Profit Margin, return on equity of -0.0064, and Current Valuation of 106.84 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Medexus Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Medexus Pharmaceuticals is based on 3 months time horizon. Increasing Medexus Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Medexus Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medexus Stock. However, Medexus Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.86 | Real 2.79 | Hype 2.86 |
The intrinsic value of Medexus Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medexus Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medexus Pharmaceuticals helps investors to forecast how Medexus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medexus Pharmaceuticals more accurately as focusing exclusively on Medexus Pharmaceuticals' fundamentals will not take into account other important factors: About Medexus Pharmaceuticals Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Medexus Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Medexus Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Medexus Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Medexus Pharmaceuticals's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medexus Pharmaceuticals. We calculate exposure to Medexus Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medexus Pharmaceuticals's related companies.Other Information on Investing in Medexus Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.